Among Doctors

First time this has happened: All 12 cancer patients involved in US study entered remission after taking dostarlimab over a six-month period.

All cancer patients in drug trial appear to be cured for ‘first time in history’ ‘This is the first time this has happened’: All 12 patients involved in US study entered remission after taking dostarlimab over a six-month period

11 clinical trials that will shape medicine in 2022 - Nature Medicine Nature Medicine asks leading researchers to name their most anticipated clinical trial for 2022, from CRISPR and psilocybin to oncolytic viruses.

Hesitant about COVID-19 vaccine development? Some people may be hesitant to be vaccinated for COVID-19 because they think COVID-19 vaccines were developed too quickly. But today's successes [...]

First patient dosed in BioNTech Phase II trial of mRNA cancer vaccine BioNTech has announced that it has commenced dosing in it's BNT111 Phase II cancer vaccine trial in advanced melanoma.

📣Among Doctors is delighted to be a media partner for , the inspirational examining the future of health! The three-episode event features a prestigious speaker faculty, featuring pioneer George Church, CEO Joanna Shields, and the CEO of Covid-19 vaccine developer Ugur Sahin.
👉Join us on March 31 to hear from the physicians, doctors and scientists who pave new ways of improving healthcare and patient care. We'll explore topics across , , , and .
➡️Get your discounted ticket here: http://bit.ly/WiredHealthAD
WIRED

WIRED Health 2021 WIRED Health is the premier conference dedicated to mapping the future of health.

: Symptoms & therapy

Gastroesophageal Reflux Disease This narrative review summarizes recent advances in the diagnosis and management of gastroesophageal reflux disease (GERD), including updates on pharmacologic options and surgical approaches.

Healthcare Professionals: Preparing for Vaccination
Review and discuss training & educational material on
https://network.amongdoctors.com/userpanel/sharepost/1087
Source: CDC

Early details of in patients reported by researchers at Massachusetts General Hospital in the American Journal of Neuroradiology

Small study reveals details of brain damage in COVID-19 patients Massachusetts General Hospital researchers examined six patients using a specialized magnetic resonance technique and found that COVID-19 patients with neurological symptoms show some of the same metabolic disturbances in the brain as patients who have suffered oxygen deprivation from other causes.

Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study

Pfizer’s Early Data Shows Vaccine Is More Than 90% Effective Pfizer announced positive early results from its coronavirus vaccine trial, cementing the lead in a frenzied global race that has unfolded at record-breaking speed.

Promising news: AstraZeneca's vaccine is expected to be ready by early next year and will be supplied to developing countries for free.

AstraZeneca to deliver vaccine trial data by year's end LONDON (AP) — AstraZeneca hopes to show its COVID-19 vaccine is effective by the end of this year and is ramping up manufacturing so it can supply hundreds of millions of doses starting in...

"What is interesting in this case, and perhaps very different to how it had been recognized at that specific time, was that the main presentation of the illness was not a respiratory symptom. It was the eye"

Researchers identify pink eye as possible primary symptom of COVID-19 A team of researchers at the University of Alberta believe a case of pink eye is now a reason to be tested for COVID-19.

can reduce the risk of infection and the impact of , new research in the US has found.

Vitamin D can cut risk of fatal Covid complications, research finds